VAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marriott Vacations Worldwide Corp (VAC) is not a strong buy for a beginner, long-term investor at this time. The company's financial performance has been poor, with significant declines in revenue, net income, and EPS. While there are some positive catalysts, such as insider buying and potential turnaround under new management, the negative catalysts, including revenue misses, legal investigations, and weak market sentiment, outweigh the positives. The technical indicators and options data suggest a neutral to slightly bearish sentiment in the short term. For a long-term investor, it would be prudent to wait for clearer signs of recovery before investing.
The MACD is positive and expanding, indicating bullish momentum. However, RSI is neutral at 67.622, and moving averages are converging, suggesting no clear trend. Key resistance levels are at R1: 70.934 and R2: 72.645, while support levels are at S1: 65.395 and S2: 63.684. The stock is currently trading near resistance levels in the pre-market, with a slight decline of -0.82%.
Insider buying has increased significantly by 14916.31% in the last month.
Analysts from firms like Mizuho, Jefferies, and Truist have upgraded the stock, citing the potential for a turnaround under new management.
The stock is trading at a discount to peers, which may present a compelling risk/reward opportunity if the turnaround is successful.
Poor financial performance in Q4 2025, with revenue down -2.73% YoY, net income down -962.00% YoY, and EPS down -1051.15% YoY.
Legal investigation by The Schall Law Firm for potentially misleading statements.
Negative sentiment from analysts like Citizens and Morgan Stanley, citing organizational dysfunction and downward revisions to estimates.
Stock trend analysis predicts a 60% chance of further declines in the short term (-0.44% next day, -1.45% next week, -7.84% next month).
In Q4 2025, Marriott Vacations reported a revenue drop to $856 million (-2.73% YoY), net income of -$431 million (-962.00% YoY), and EPS of -12.46 (-1051.15% YoY). Gross margin improved slightly to 71.61% (+0.99% YoY), but overall financials indicate significant challenges.
Analyst sentiment is mixed. Positive upgrades from Mizuho, Jefferies, and Truist highlight potential for a turnaround under new management, with price targets ranging from $97 to $105. However, Citizens downgraded the stock to Market Perform, citing organizational dysfunction, and Morgan Stanley downgraded it to Underweight with a price target of $52, citing concerns about the broader sector and the company's performance.
